MarketCapTrends
BCRX
BioCryst Pharmaceuticals Inc. (BCRX)
NASDAQ · Healthcare

BioCryst Pharmaceuticals Inc. Cash on Hand 2009–2025

BioCryst Pharmaceuticals Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • BioCryst Pharmaceuticals Inc. cash on hand for the quarter ending December 31, 2025 were 89.7M, a 14.30% decrease year-over-year.
  • BioCryst Pharmaceuticals Inc. cash on hand for 2025 were 89.7M, a 14.30% decrease from 2024.
  • BioCryst Pharmaceuticals Inc. cash on hand for 2024 were 104.7M, a 5.36% decrease from 2023.
  • BioCryst Pharmaceuticals Inc. cash on hand for 2023 were 110.6M, a 63.70% decrease from 2022.
  • BioCryst Pharmaceuticals Inc. cash on hand for 2022 were 304.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
BioCryst Pharmaceuticals Inc. Annual Cash on Hand (Millions of US $)
2025$90
2024$105
2023$111
2022$305
2021$504
2020$272
2019$114
2018$27
2017$50
2016$22
2015$29
2014$55
2013$21
2012$21
2011$16
BioCryst Pharmaceuticals Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$90
2024-12-31$105
2023-12-31$111
2022-12-31$305
2021-12-31$504
2020-12-31$272
2019-12-31$114
2018-12-31$27
2017-12-31$50
2016-12-31$22
2015-12-31$29
2014-12-31$55
2013-12-31$21
2012-12-31$21
2011-12-31$16
2010-12-31$14

BioCryst Pharmaceuticals Inc. Cash on Hand — FAQ

BioCryst Pharmaceuticals Inc. (BCRX) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BCRX's cash on hand history?

The chart and table above show BioCryst Pharmaceuticals Inc.'s cash on hand by year and by quarter, including the growth rate.